Indications: LYBALVI® is indicated for the treatment of adults with schizophrenia or bipolar I disorder for acute treatment of manic or mixed episodes as monotherapy and as an adjunct to lithium or valproate, or as a maintenance monotherapy treatment.


Register today

for LYBALVI (olanzapine and samidorphan) updates and request to meet with a sales representative

Man representing a healthcare provider speaking to a sales representative
Actor portrayals.

Your local representative can provide you with information on LYBALVI and how to request product samples.

Please complete the form below so your representative can follow up with you directly.

Virtual appointments are available.


Thank you for submitting a request. Your LYBALVI Sales Representative will follow up with you directly. Also, be sure to check your inbox for more information about LYBALVI.

Sign up today to get LYBALVI information, educational resources, and updates delivered to your inbox.


Thank you for signing up for updates about LYBALVI. Be sure to check your inbox for updates.